Issue

Vol. 63 No. 5: Issue 5

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Co-incubation of PMN and CaCo-2 cells modulates inflammatory potential

https://doi.org/10.14715/cmb/2017.63.5.22
M. B. Schaefer
University of Giessen Lung Center (UGLC), University Hospital of Giessen and Marburg, Giessen, Germany
C. A. Schaefer
Department of Internal Medicine II, University Hospital of Bonn, Bonn, Germany
M. Hecker
University of Giessen Lung Center (UGLC), University Hospital of Giessen and Marburg, Giessen, Germany
R. E. Morty
Department of Lung Development and Remodelling, Max-Planck-Institute, Bad Nauheim, Germany
M. Witzenrath
Department of Infectious Diseases, Charité, University of Berlin, Berlin, Germany
W. Seeger
University of Giessen Lung Center (UGLC), University Hospital of Giessen and Marburg, Giessen, Germany
K. Mayer
University of Giessen Lung Center (UGLC), University Hospital of Giessen and Marburg, Giessen, Germany

Corresponding Author(s) : K. Mayer

konstantin.mayer@innere.med.uni-giessen.de

Cellular and Molecular Biology, Vol. 63 No. 5: Issue 5

Abstract

Polymorphonuclear granulocytes (PMN) are activated in inflammatory reactions. Intestinal epithelial cells are relevant for maintaining the intestinal barrier. We examined interactions of PMN and intestinal epithelial cell-like CaCo-2 cells to elucidate their regulation of inflammatory signalling and the impact of cyclooxygenase (COX), nitric oxide (NO) and platelet-activating factor (PAF). Human PMN and CaCo-2 cells, separately and in co-incubation, were stimulated with the calcium ionophore A23187 or with N-Formyl-methionyl-leucyl-phenylalanin (fMLP) that activates PMN only. Human neutrophil elastase (HNE) and respiratory Burst were measured. To evaluate the modulation of inflammatory crosstalk we applied inhibitors of COX (acetyl salicylic acid; ASA), NO-synthase (N-monomethyl-L-arginin; L-NMMA), and the PAF-receptor (WEB2086). Unstimulated, co-incubation of CaCo-2 cells and PMN led to significantly reduced Burst and elevated HNE as compared to PMN. After stimulation with A23187, co-incubation resulted in an inhibition of Burst and HNE. Using fMLP co-incubation failed to modulate Burst but increased HNE. Without stimulation, all three inhibitors abolished the effect of co-incubation on Burst but did not change HNE.  ASA partly prevented modulation of Burst L-NMMA and WEB2086 did not change Burst but abolished mitigation of HNE. Without stimulation, co-incubation reduced Burst and elevated HNE. Activation of PMN and CaCo-2 cells by fMLP as compared to A23187 resulted in a completely different pattern of Burst and HNE, possibly due to single vs. dual cell activation. Anti-inflammatory effect of co-incubation might in part be due to due to COX-signalling governing Burst whereas NO- and PAF-dependent signalling seemed to control HNE release.

Keywords

Polymorphonuclear granulocytes CaCo-2 cells Inflammation Nitric oxide Platelet-activating factor.
Schaefer, M. B., Schaefer, C. A., Hecker, M., Morty, R. E., Witzenrath, M., Seeger, W., & Mayer, K. (2017). Co-incubation of PMN and CaCo-2 cells modulates inflammatory potential. Cellular and Molecular Biology, 63(5), 119–126. https://doi.org/10.14715/cmb/2017.63.5.22
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Sanchez de Medina F, Romero-Calvo I, Mascaraque C, Martinez-Augustin O. Intestinal inflammation and mucosal barrier function. Inflammatory bowel diseases 2014; 20(12):2394-2404.
  2. Parlesak A, Haller D, Brinz S, Baeuerlein A, Bode C. Modulation of cytokine release by differentiated CACO-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scandinavian journal of immunology 2004; 60(5):477-485.
  3. Klingensmith NJ, Coopersmith CM. The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness. Critical care clinics 2016; 32(2):203-212.
  4. Marshall JC, Dellinger RP, Levy M. The Surviving Sepsis Campaign: a history and a perspective. Surgical infections 2010; 11(3):275-281.
  5. Jeon SY, Kim EA, Ma YW, Kim JP, Jung TG, Hwang EG. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. The Annals of otology, rhinology, and laryngology 2001; 110(1):83-86.
  6. Hossain M, Qadri SM, Liu L. Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. Journal of inflammation 2012; 9(1):28.
  7. Bussolati B, Mariano F, Migliori M, Camussi G. Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes. Kidney international 2002; 62(4):1322-1331.
  8. Melnikova V, Bar-Eli M. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer metastasis reviews 2007; 26(3-4):359-371.
  9. Whittle BJ. Nitric oxide--a mediator of inflammation or mucosal defence. European journal of gastroenterology & hepatology 1997; 9(11):1026-1032.
  10. Carbone F, Mach F, Montecucco F. Update on the role of neutrophils in atherosclerotic plaque vulnerability. Current drug targets 2015; 16(4):321-333.
  11. Diebel LN, Liberati DM, Taub JS, Diglio CA, Brown WJ. Intestinal epithelial cells modulate PMN activation and apoptosis following bacterial and hypoxic challenges. The Journal of trauma 2005; 58(6):1126-1133.
  12. Kessenbrock K, Dau T, Jenne DE. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. Journal of molecular medicine 2011; 89(1):23-28.
  13. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury. International journal of cardiology 2002; 86(1):41-59.
  14. Grailer JJ, Kalbitz M, Zetoune FS, Ward PA. Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis. Journal of innate immunity 2014; 6(5):695-705.
  15. Lei Y, Wang K, Deng L, Chen Y, Nice EC, Huang C. Redox regulation of inflammation: old elements, a new story. Medicinal research reviews 2015; 35(2):306-340.
  16. Doskocil I, Havlik J, Verlotta R, Tauchen J, Vesela L, Macakova K et al. In vitro immunomodulatory activity, cytotoxicity and chemistry of some central European polypores. Pharmaceutical biology 2016:1-8.
  17. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K et al. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. Journal of immunology 2004; 172(5):3051-3058.
  18. Rotondo S, Dell'Elba G, Krauze-Brzosko K, Manarini S, Martelli N, Pecce R et al. Licofelone, a dual lipoxygenase-cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet function. European journal of pharmacology 2002; 453(1):131-139.
  19. Schaible AM, Traber H, Temml V, Noha SM, Filosa R, Peduto A et al. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. Biochemical pharmacology 2013; 86(4):476-486.
  20. Guo M, Yuan SY, Frederich BJ, Sun C, Shen Q, McLean DL et al. Role of non-muscle myosin light chain kinase in neutrophil-mediated intestinal barrier dysfunction during thermal injury. Shock 2012; 38(4):436-443.
  21. Carlson RM, Vavricka SR, Eloranta JJ, Musch MW, Arvans DL, Kles KA et al. fMLP induces Hsp27 expression, attenuates NF-kappaB activation, and confers intestinal epithelial cell protection. American journal of physiology Gastrointestinal and liver physiology 2007; 292(4):G1070-1078.
  22. Mayer K, Fegbeutel C, Hattar K, Sibelius U, Kramer HJ, Heuer KU et al. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003; 29(9):1472-1481.
  23. Cohen HJ, Chovaniec ME. Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system. The Journal of clinical investigation 1978; 61(4):1081-1087.
  24. Grimminger F, Hattar K, Papavassilis C, Temmesfeld B, Csernok E, Gross WL et al. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation. The Journal of experimental medicine 1996; 184(4):1567-1572.
  25. Henson PM. The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. J Immunol 1971; 107(6):1547-1557.
  26. Kramps JA, van Twisk C, van der Linden AC. L-Pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scand J Clin Lab Invest 1983; 43(5):427-432.
  27. Wenzel U, Gebert I, Weintraut H, Weber WM, Clauss W, Daniel H. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. The Journal of pharmacology and experimental therapeutics 1996; 277(2):831-839.
  28. Allen CA, Broom MF, Chadwick VS. Flow cytometry analysis of the expression of neutrophil FMLP receptors. Journal of immunological methods 1992; 149(2):159-164.
  29. Amin PB, Diebel LN, Liberati DM. The intestinal epithelial cell modulates the effect of alcohol on neutrophil inflammatory potential. The Journal of trauma 2007; 63(6):1223-1229.
  30. Deitch EA, Haskel Y, Cruz N, Xu D, Kvietys PR. Caco-2 and IEC-18 intestinal epithelial cells exert bactericidal activity through an oxidant-dependent pathway. Shock 1995; 4(5):345-350.
  31. Amin PB, Diebel LN, Liberati DM. Secretory immunoglobulin a blunts gut-mediated priming of neutrophils in vitro. The Journal of trauma 2008; 64(6):1437-1442.
  32. Wang L, Li Q, Duan XL, Chang YZ. Effects of extracellular iron concentration on calcium absorption and relationship between Ca2+ and cell apoptosis in Caco-2 cells. World journal of gastroenterology 2005; 11(19):2916-2921.
  33. Rose F, Hattar K, Gakisch S, Grimminger F, Olschewski H, Seeger W et al. Increased neutrophil mediator release in patients with pulmonary hypertension--suppression by inhaled iloprost. Thrombosis and haemostasis 2003; 90(6):1141-1149.
  34. Foster DR, Zheng X. Cephalexin inhibits N-formylated peptide transport and intestinal hyperpermeability in Caco2 cells. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2007; 10(3):299-310.
  35. Zen K, Guo YL, Li LM, Bian Z, Zhang CY, Liu Y. Cleavage of the CD11b extracellular domain by the leukocyte serprocidins is critical for neutrophil detachment during chemotaxis. Blood 2011; 117(18):4885-4894.
  36. Fukui A, Naito Y, Handa O, Kugai M, Tsuji T, Yoriki H et al. Acetyl salicylic acid induces damage to intestinal epithelial cells by oxidation-related modifications of ZO-1. American journal of physiology Gastrointestinal and liver physiology 2012; 303(8):G927-936.
  37. Egger G, Burda A, Obernosterer A, Mitterhammer H, Kager G, Jurgens G et al. Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin. Inflammation 2001; 25(2):129-135.
  38. Kennedy M, Wilson L, Szabo C, Salzman AL. 5-aminosalicylic acid inhibits iNOS transcription in human intestinal epithelial cells. International journal of molecular medicine 1999; 4(4):437-443.
  39. Brasse-Lagnel C, Lavoinne A, Fairand A, Vavasseur K, Deniel N, Husson A. Biphasic effect of IL-1beta on the activity of argininosuccinate synthetase in Caco-2 cells. Involvement of nitric oxide production. Biochimie 2006; 88(6):607-612.
  40. Banan A, Fields JZ, Decker H, Zhang Y, Keshavarzian A. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. The Journal of pharmacology and experimental therapeutics 2000; 294(3):997-1008.
  41. Chavez AM, Menconi MJ, Hodin RA, Fink MP. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Critical care medicine 1999; 27(10):2246-2251.
  42. Partrick DA, Moore EE, Offner PJ, Barnett CC, Barkin M, Silliman CC. Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway. Surgery 1997; 122(2):196-202; discussion 202-193.
  43. Merendino N, Dwinell MB, Varki N, Eckmann L, Kagnoff MF. Human intestinal epithelial cells express receptors for platelet-activating factor. The American journal of physiology 1999; 277(4 Pt 1):G810-818.
  44. Borthakur A, Bhattacharyya S, Kumar A, Anbazhagan AN, Tobacman JK, Dudeja PK. Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells. PloS one 2013; 8(10):e75664.
  45. Borthakur A, Bhattacharyya S, Alrefai WA, Tobacman JK, Ramaswamy K, Dudeja PK. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflammatory bowel diseases 2010; 16(4):593-603.
  46. Partrick DA, Moore EE, Moore FA, Barnett CC, Silliman CC. Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils. The Journal of trauma 1997; 43(2):297-302; discussion 302-293.
  47. Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest 1997; 100(11 Suppl):S3-5.
  48. Egea L, Gimenez R, Lucia D, Modolell I, Badia J, Baldoma L et al. Increased production of the ether-lipid platelet-activating factor in intestinal epithelial cells infected by Salmonella enteritidis. Biochimica et biophysica acta 2008; 1781(5):270-276.
  49. Takahashi S, Yoshikawa T, Naito Y, Tanigawa T, Yoshida N, Kondo M. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes. Lipids 1991; 26(12):1227-1230.
  50. Wiedow O, Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. Journal of internal medicine 2005; 257(4):319-328.
  51. Bjornland K, Buo L, Scott H, Konttinen Y, Johansen HT, Aasen AO. Polymorphonuclear elastase in human colorectal carcinoma. International journal of oncology 1998; 12(3):535-540.
  52. Brazil JC, Lee WY, Kolegraff KN, Nusrat A, Parkos CA, Louis NA. Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface. Journal of immunology 2010; 185(11):7026-7036.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 815 Download : 332